Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2020 Financial Results and Recent Corporate Developments

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. SPCX
4. ACN
5. IBM
6. SPY
7. DPZ
8. NVDA
9. PRIM
10. META

Go back to Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2020 Financial Results and Recent Corporate Developments

Sarepta Therapeutics (SRPT) Misses Q4 EPS by 7c, Revenue Misses

March 1, 2021 4:20 PM EST

Sarepta Therapeutics (NASDAQ: SRPT) reported Q4 EPS of ($1.84), $0.07 worse than the analyst estimate of ($1.77). Revenue for the quarter came in at $122.6 million versus the consensus estimate of $146.3 million.

For earnings history and earnings-related data on Sarepta Therapeutics (SRPT) click here.

... More